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Exercise Testing in Asymptomatic Patients
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Serge C. Harb, MD; Thomas Cook, MPH, PhD; Wael A. Jaber, MD; Thomas H. Marwick, MD, PhD, MPH
Background:Although exercise echocardiography (ExE)
of asymptomatic patients early (2 years after percuta-
neous coronary intervention [PCI] or5 years after coro-
nary bypass graft surgery [CABG]) after revasculariza-
tion is considered inappropriate, the appropriateness of
later testing is indeterminate. Treatment responses to posi-
tive test results in either setting have uncertain outcome
implications. We sought to identify whether predictors
of increased risk by ExE could lead to interventions that
change outcome in asymptomatic patients with previ-
ous coronary revascularization.
Methods: Exercise echocardiography was performed
in 2105 asymptomatic patients (mean [SD] age, 64 [10]
years; 310 [15%] were women; 845 [40%] had a history
of myocardial infarction; 1143 [54%] had undergone
PCI and 962 [46%] had undergone CABG 4.1 [4.7]
years prior to the ExE). Ischemia was identified as a
new or worsening wall motion abnormality. Patients
were followed for a mean (SD) period of 5.7 (3.0) years
for cardiac mortality. The association of ischemia dur-
ing ExE with survival was assessed using Cox propor-
tional hazard models, and an interaction with revascu-
larization was sought.
Results: Of 262 patients with ischemia (13%), only 88
(34%) underwent subsequent revascularization. Mortal-
ity (97patients [4.6%])was associatedwith ischemia (haz-
ard ratio, 2.10; 95%CI, 1.05-4.19; P=.04) in groups tested
both early (P=.03) and late (2 years after PCI or  5
years after CABG) (P=.001). However, the main predic-
tors of outcome were clinical and stress testing findings
rather than echocardiographic features. Subgroup analy-
sis showed that asymptomatic patients without diabetes
mellitus, with normal ejection fraction (50%), and nor-
mal exercise capacity (6 METs [metabolic equivalent
for task]) were unlikely to have a positive test result or
events. Even high-risk patients did not seem to benefit
from repeated revascularization.
Conclusions:Asymptomatic patients who undergo ExE
after coronary revascularizationmay be identified as being
at high risk but do not seem to have more favorable out-
comeswith repeated revascularization. Fromahealth eco-
nomic standpoint, appropriateness of such testing must
be carefully reviewed.
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R ECURRENT ISCHEMIA ANDcardiac events are commonafter coronary revascular-ization procedures—bothpercutaneous coronary in-
tervention (PCI) and coronary bypass graft
surgery (CABG).1,2 This reflects the pro-
gression of coronary artery disease as well
as progressive failure of treatment, includ-
ing in-stent restenosis and graft atheroscle-
rosis. In symptomatic patients after revas-
cularization, the American College of
Cardiology/American Heart Association
(ACC/AHA) guidelines recommend evalu-
ation with stress imaging tests,3 including
exercise stress echocardiography (ExE).
The evaluation of asymptomatic patients is
more controversial. The presence of ische-
mia on a stress echocardiogram is predic-
tive of adverse outcome in post-PCI and
post-CABGpatients.4-6However, there is no
evidence that repeated revascularization
(RVS) based onpositive testing changes the
course of the disease or patient outcomes.
The inappropriate use of noninvasive
testing is not only costly but also could lead
to unnecessary downstream testing and in-
terventions such as coronary angiogra-
phy and revascularization. While stress
echocardiography in postrevasculariza-
tion patients with ischemic symptoms is
appropriate,7 appropriateness in asymp-
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tomatic patients depends on the timing relative to inter-
vention. Testing is considered inappropriate early after
PCI (2 years) and CABG (5 years),7 but the justifi-
cation for these cutoffs is ill defined.We sought to study
the effectiveness of testing asymptomatic patients early
and late postrevascularization by examining the fre-
quency of a positive response, the association of test re-
sultswith subsequent revascularization andmortality, and
the presence of any interaction of revascularization with
these event rates.
METHODS
STUDY DESIGN
This was an observational retrospective cohort study using pro-
spectively obtained data in consecutive asymptomatic pa-
tients with a history of PCI or CABGwhowere referred for ExE
at the Cleveland Clinic, Cleveland, Ohio, from January 2000
through November 2010. Our institution has no formal pro-
tocol regarding the assessment of patients who have had CABG
or PCI and are symptom free; referral for ExE is solely at the
discretion of individual physician treating the patient, usually
on the basis of concerns regarding risk factor status or incom-
plete revascularization.
CLINICAL INFORMATION
Before each ExE, a structured interview and medical chart
review were done to gather data on demographics (age, sex),
previous cardiac revascularization procedure (type, date), symp-
toms (chest pain, dyspnea), medications (aspirin, angiotensin-
converting enzyme [ACE] inhibitors, angiotensin II receptor
blockers [ARBs], statins,-blockers), coronary risk factors (hy-
pertension, diabetes mellitus, obesity [body mass index, cal-
culated as weight in kilograms divided by height in meters
squared, 30], smoking), previous cardiovascular events (myo-
cardial infarction [MI], stroke), and several cardiac and non-
cardiac diagnoses (atrial fibrillation [AF], congestive heart fail-
ure [CHF], and chronic obstructive pulmonary disease [COPD]).
This clinical information was entered prospectively into the
stress-testing database. The symptom status of patients was as-
sessed by 2 independent reviewers who were blinded to each
other’s assessments andwhowere both unaware of the hypoth-
esis of this study: 1 reviewer was from the registry group while
the other was the exercise physiologist supervising the study.
Only patients whowere considered to be symptom free by both
reviewers were included. Based on Appropriate Use Criteria,7
“early” testing was defined by investigation as testing less than
2 years after PCI or less than 5 years after CABG.
Information regarding revascularization was obtained by
matching to the Cardiovascular Information Registry, a com-
prehensive database describing clinical and surgical character-
istics of revascularized patients,8 which includes prospective
follow-up for death, recurrent symptoms, and RVS. The data-
bases and linkage were approved by the institutional review
board.
EXERCISE TESTING
Patients were prepared for exercise echocardiography in the tra-
ditionalway,9 including abstaining from blockade for 24 hours
before the test. Maximal treadmill protocols, selected accord-
ing to the patient age and functional status, were performed,
and standard test end points were used.10 Ischemic symptoms,
changes in ST segment, exercise capacity, and hemodynamic
response to exercise were recorded for each patient. Exercise
time, maximum ST-segment deviation, and the presence of ex-
ercise anginawere used to calculate the Duke Treadmill score.11
In addition, we combined clinical (age, sex, angina, diabetes
mellitus, smoking, hypertension) and stress data (exercise ca-
pacity, ST depression, angina, heart-rate recovery, ectopy dur-
ing recovery) to derive a 5-year mortality risk index12 as pre-
viously described.
ECHOCARDIOGRAPHY
Baseline and stress images (performed immediately after ces-
sation of exercise) were acquired from standard echocardio-
graphic windows, including apical, parasternal, and subcos-
tal.13 Studies were interpreted by experienced physicians, aware
of the test indication but not of other clinical details of the pa-
tient. Standard left ventricular (LV) segmentation was used for
LV regionalwallmotion analysis.14 Normal resting functionwith
no worsening after exercise identified a normal test. Scar was
characterized by akinesis or dyskinesis at rest. Ischemia was
defined by new or worsening wall motion abnormalities. To
express the extent of ischemia, myocardial segments were com-
bined into vascular territories. Study results were considered
abnormal if more than 1 segment showed evidence of ische-
mia or MI, and a normal study was defined by a normal re-
sponse in all segments.
END POINTS
The primary end points were RVS and cardiac as well as all-
causemortality during amean (SD) follow-up period of 5.7 (3.0)
years. Repeated revascularization was attributed to the ExE re-
sult if it was performedwithin 6months. End points were iden-
tified from the electronic medical record, state death records,
and a national social security death index. End points were veri-
fied by reviewers who were not aware of stress testing or echo-
cardiography results.
STATISTICAL ANALYSIS
Differences in mortality between patients with and without is-
chemia during exercise echocardiography were evaluated by
log-rank 2 tests and compared using Kaplan-Meier survival
curves. Adjusted estimates and tests were obtained using Cox
proportional hazard models with adjustment for age, sex, type
of prior revascularization (PCI vs CABG), ejection fraction, ex-
ercise capacity, smoking status, diabetes mellitus, hyperten-
sion, cardiovascular medications (aspirin, -blockers, ACE in-
hibitors, ARBs, and statins), and cardiac history of AF, CHF,
and MI. Log-likelihood ratio tests were used to evaluate any
interaction terms. A series of subgroup analyses were per-
formed in asymptomatic patients with low ejection fraction (EF
50%), diabetesmellitus, and low exercise capacity (6METs
[metabolic equivalent for task]). Nested Cox regression mod-
els were used to assess the contribution of clinical factors, stress
testing findings, and echocardiographic features in the predic-
tion of mortality.
RESULTS
PATIENT CHARACTERISTICS
We identified 2105 patients with previous revascular-
ization—1143 with prior PCI (54%) and 962 with prior
CABG (46%)—whowere asymptomatic at time of refer-
ral for the first follow-up ExE from January 2000
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through November 2010. Their baseline clinical char-
acteristics are summarized in Table 1. Of note, 40%
had a history of MI, and the revascularization proce-
dure had been performed at a mean (SD) of 4.1 (4.7)
years prior to the exercise echocardiogram. Late testing
(2 years post-PCI and5 years post-CABG) was per-
formed in 434 PCI patients (38%) and 435 CABG pa-
tients (45%). The stress results overall suggested low
risk—the mean exercise capacity was 8.7 (2.4) METs
and the mean resting ejection fraction was 53% (8%).
Ischemia was noted in 262 patients (13%), but only
1158 (55%) were completely normal.
REPEATED TESTING
Ischemia was detected at the index test in 262 patients,
of whom 88 (34%) underwent RVS. Among those with
a nonischemic index test, 908 patients (49%) had a sec-
ond or subsequent test (Figure 1). Of these patients,
the rate of initial or subsequent revascularization ranged
from about 33% of those with a positive test result to 17%
of symptomatic patientswithout ischemia and12% to 14%
of asymptomatic patients without ischemia.
REPEATED REVASCULARIZATION
In total, RVS was performed in 354 patients (17%) after
a mean (SD) interval of 3.7 (3.2) years from the index
ExE—mostly as PCI (12%), although 4% had CABG and
1% had both PCI and CABG (Table 2). The relation-
ship between ischemia on the initial ExE and RVS is sum-
marized as follows: 262 patients (13%) had ischemia, and
of those, 174 (66%) did not undergo RVS. A total of 1845
patients (87%) did not have ischemia, and of these, 1579
(86%) did not undergo RVS. Among those who under-
went RVS, 266 (75%) did not have ischemia on the ini-
tial exercise echocardiogram. However, RVS was asso-
ciatedwith the detection of ischemia on subsequent testing
(63 patients [24%]) performed for the development of
spontaneous symptoms. Patients who developed symp-
toms were about twice as likely undergo RVS. By com-
parison, of the 1579who did not undergoRVS, 197 (12%)
became symptomatic at follow-up. The decision to pro-
ceed with RVS was based more on the clinical status of
the patient than on the sole result of the test. Table 3,
showing patients who had ischemia at any test, com-
pares clinical characteristics in those who did and did not
Table 1. Baseline Characteristics of 2105 Asymptomatic Patients With Prior Revascularization at Time of First Follow-up ExE
Characteristic
Patients, No. (%)
Total
(N = 2105)
Prior CABG
(n = 962)
Prior PCI
(n = 1143)
Age, mean (SD), y 64 (10) 66 (9) 62 (10)
Female 310 (15) 111 (12) 197 (17)
Early testinga 1236 (59) 527 (55) 709 (62)
Medical history
Atrial fibrillation 99 (5) 55 (6) 44 (4)
CHF 110 (5) 69 (7) 41 (4)
MI 845 (40) 306 (32) 537 (47)
Other conditions/risk factors
COPD 56 (3) 32 (3) 24 (2)
Stroke 120 (6) 70 (7) 50 (4)
Obesity 299 (14) 148 (15) 174 (15)
Current smoker 160 (8) 58 (6) 102 (9)
Hypertension 1573 (75) 715 (74) 857 (75)
Diabetes mellitus 419 (20) 203 (21) 215 (19)
Use of cardiac medications
Aspirin 1767 (84) 779 (81) 986 (86)
ACE inhibitors 1022 (49) 429 (45) 593 (52)
-Blockers 1473 (70) 628 (65) 843 (74)
ARB 213 (10) 96 (10) 116 (10)
Statins 1796 (85) 799 (83) 995 (87)
Duke treadmill score
Abnormal, 5 467 (22) 217 (22) 250 (22)
ST-segment uninterpretable 239 (11) 142 (15) 96 (8)
Normal, 5 1399 (66) 603 (63) 797 (70)
ExE test result
Ischemia 262 (13) 125 (13) 137 (12)
Nondiagnostic or scar only 685 (32) 349 (36) 336 (29)
Normal 1158 (55) 488 (51) 670 (59)
Maximum METs, mean (SD) 8.7 (2.4) 8.4 (2.3) 8.9 (2.4)
Ejection fraction, mean (SD) 53 (8) 52 (9) 53 (8)
5-y Survival index, mean (SD) 0.93 (0.08) 0.92 (0.09) 0.95 (0.07)
Abbreviations: ACE, angiotensin-converting enzyme; ARB, angiotensin II receptor blockers; CABG, coronary artery bypass graft; CHF, congestive heart failure;
COPD, chronic obstructive pulmonary disease; ExE, exercise echocardiography; MET, metabolic equivalent for task; MI, myocardial infarction; PCI, percutaneous
coronary intervention.
aEarly testing: less than 2 years after PCI and less than 5 years after CABG.
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undergo RVS. Symptom status was the only variable sig-
nificantly associated with the decision to proceed with
RVS among patients with ischemia (P = .008).
MORTALITY DURING FOLLOW-UP
Ninety-seven deaths (4.6%) occurred over a mean (SD)
period of 5.7 (3.0) years of follow-up, an annualizedmor-
tality rate of 0.8%. Patients with ischemia on any post-
revascularization ExE had a higher mortality compared
with those without ischemia (8.0% vs 4.1%; P = .03).
Figure 2 summarizes the difference in cardiac and all-
cause mortality between patients with and without is-
chemia. Most deaths (76 patients [78%]) occurred in pa-
tients without ischemia, among whom the annualized
mortality rate was 0.7% with RVS and 0.8% in patients
without RVS (P = .15). There were 21 deaths in patients
with ischemia, among whom the annualized mortality
rates were 1.4% with RVS and 2.1% in patients without
RVS (P = .38). By comparison, there were 20 deaths in
the scar group (annualized mortality rate, 1.0%) and 32
deaths in the nondiagnostic group (annualized mortal-
ity rate, 1.4%).
The independent associations of clinical, stress test-
ing, and echocardiographic characteristics with mortal-
ity are summarized in Table4. Ischemia on exercise echo-
cardiographywas strongly associated with death (hazard
ratio [HR], 2.10; 95%CI, 1.05-4.19; P = .04). PriorCABG,
an abnormal ExE result even without ischemia (ie, scar
or nondiagnostic), an EF of less than 50%, an exercise
capacity of less than 6METs, and diabetes mellitus were
also associated with death. However, to be useful clini-
cally, ExE needs to be not only of independent value but
also incremental value. In nestedmodels (Table5), clini-
cal and stress testing findings, but not echocardio-
graphic features, were associated with both all-cause and
cardiac mortality. Accordingly, we applied the predic-
tive index based on clinical and exercise but no echo-
Asymptomatic patients2105
With ischemia262
With RVS88
With ischemia,
with symptoms
92
With RVS
(A = 0.0)
22 Without
RVS
(A = 0.9)
70 With RVS
(A = 0.0)
26 Without
RVS
(A = 0.0)
20 With RVS
(A = 0.0)
37 Without
RVS
(A = 0.1)
177 With RVS
(A = 0.6)
67 Without
RVS
(A = 0.4)
489 With RVS
(A = 1.0)
114 Without
RVS
(A = 1.3)
821
With ischemia,
without symptoms
46 Without ischemia,
with symptoms
214 Without ischemia,
without symptoms
556
Without RVS174 With repeated ExE908 Without repeated ExE935
Without ischemia1843
Figure 1. Index exercise echocardiogram and outcomes. A indicates annualized mortality rate in percentages; ExE, exercise echocardiography; and RVS, repeated
revascularization.
Table 2. Characteristics of Index Revascularization
and Subsequent Revascularizations
Characteristic
Patients, No. (%)
Total
(N=2105)
CABG
(n=962)
PCI
(n=1143)
Time from index revascularization
to first ExE, mean (SD), y
4.0 (4.7) 6.0 (5.6) 2.4 (2.7)
Ever symptomatic at a subsequent ExE 285 (14) 120 (12) 165 (14)
Time to development of symptoms,
mean (SD), y
2.9 (2.0) 3.0 (2.0) 2.8 (2.1)
Revascularizations after initial ExE
No revascularizations 1751 (83) 830 (86) 921 (81)
PCI 260 (12) 89 (9) 171 (15)
CABG 77 (4) 38 (4) 39 (3)
PCI CABG 17 (1) 5 (1) 12 (1)
Time to repeated revascularization
after the initial ExE, mean (SD), y
3.7 (3.2) 4.8 (3.3) 3.2 (3.0)
Abbreviations: CABG, coronary artery bypass graft; ExE, exercise
echocardiography; PCI, percutaneous coronary intervention.
Table 3. Characteristics of Patients With Ischemia at Any
ExE Postrevascularization (First or Subsequent Follow-ups)
and Referral for Repeated Revascularization (RVS)
Characteristic
Patients, %
P Value
Repeated
RVS
No
Repeated
RVS
Symptomatic at time
of ExE
17.0 11.9 .008
Age  65 y 50.7 56.1 .34
Male 87.5 81.8 .12
DM 22.1 25.0 .63
HTN 70.6 75.8 .26
Smoking 9.6 7.2 .41
Low EF 50% 33.1 31.4 .74
Abnormal Ex capacity
6 METs
11.9 8.9 .59
Marked ischemia on
the ExE
25.8 22.0 .42
Abbreviations: DM, diabetes mellitus; EF, ejection fraction; Ex, exercise;
ExE, exercise echocardiography; HTN, hypertension; MET, metabolic
equivalent for task.
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cardiographic variables. When comparing patients with
a predicted probability of 5-year survival below the me-
dian (ie, 4.0% risk of mortality over 5 years) to pa-
tients with higher predicted survival, the first group had
a higher incidence of ischemia (15.7% vs 9.3%; P .001)
and a higher mortality rate (13.3% vs 3.9%; P  .001).
PROGNOSTIC IMPACT OF RVS
In the overall population, RVS was not significantly as-
sociated with survival (P = .67); Figure 3 compares the
adjusted survival of patients according to the presence
of ischemia and subsequent revascularization. This lack
of association persisted even after considering interac-
tion with an abnormal ExE (P = .70 for interaction with
ischemia;P = .41 for interactionwith other abnormal find-
ings, ie, scar or nondiagnostic). Subanalysis based on the
magnitude of ischemia comparing patients with mild is-
chemia with those with moderate or marked ischemia
showed that therewas nodifference regarding benefit from
revascularization. Using stratification by groups de-
fined by a single cardiac risk factor, including EF of less
than 50%, exercise capacity of less than 6METs, incom-
plete revascularization, prior CHF or MI, or presence of
diabetesmellitus or hypertension, wewere unable to iso-
late subgroups of asymptomatic patients whomight ben-
efit from testing and revascularization. Because the study
was underpowered to detect differential risks among small
subgroups, we also examined a compositemeasure of car-
diac risk. Patients at low risk (age65 years, no diabe-
tes mellitus, nonsmoker) accounted for 775 patients
(37%), and 91% had no ischemia (in contrast with 85%
among the 1330 [63%] high-risk patients; P .001). Al-
though the RVS rate was similar (15% vs 18%; P = .14),
the mortality of the low-risk group was less (4.3% vs
11.2%; P .001). Table 6 presents an alternative strati-
fication based on the 5-year mortality index.
OUTCOMES ACCORDING TO
TIMING OF THE ExE
The appropriateness criteria distinguish between test-
ing early and late postrevascularization. Early testing was
performed in 709 PCI patients (62%), and 527CABG pa-
tients (55%). RVSwas less associated with early than late
ischemia (28% vs 38%; P  .001). Ischemia on ExE was
a predictor of mortality in patients tested early (P = .03)
and late after revascularization (P = .001). However, RVS
did not significantly improve survival in patients tested
either early or late. The timing of the ExE (early vs late)
did not predict mortality in multivariate Cox regression
(HR, 0.89; 95% CI, 0.56-1.40; P = .61) (Table 4).
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Figure 2. Survival by ischemia status at first postrevascularization stress
echo among 2105 asymptomatic patients. A, All-cause death; B, cardiac-related
death.
Table 4. Multivariate Cox Regression Model Predicting Risk
of Cardiac Death With Interactions Between ExE Test Result
and Subsequent Revascularization
Characteristic HR (95% CI) P Value
Age 1.00 (0.98-1.03) .87
Female 0.67 (0.35-1.28) .22
Prior CABG 2.39 (1.42-3.99) .001
Revascularization 1.57 (0.21-11.9) .66
Cardiac history
MI 0.63 (0.39-1.02) .06
Atrial fibrillation 0.80 (0.19-3.39) .76
CHF 1.71 (0.93-3.14) .08
Risk factors
Diabetes mellitus 1.66 (1.05-2.61) .03
Current smoker 1.07 (0.48-2.42) .87
Hypertension 1.50 (0.86-2.63) .16
Obesity 1.17 (0.66-2.07) .60
Stroke 1.15 (0.56-2.36) .71
COPD 1.25 (0.50-3.09) .63
Drug use
Aspirin 0.79 (0.49-1.29) .36
ACE inhibitors 1.25 (0.77-2.01) .37
-Blockers 0.70 (0.45-1.11) .13
ARB 1.38 (0.71-2.70) .35
Statins 0.92 (0.56-1.52) .75
EF 0.97 (0.95-0.99) .02
Early vs late ExE 0.89 (0.56-1.40) .61
ExE ischemia 2.10 (1.05-4.19) .04
Other, scar, nondiagnostic 1.95 (1.07-3.54) .03
Exercise capacity, maximum
METs
0.82 (0.73-0.93) .003
Interactions
Ischemia  revascularization 0.63 (0.06-6.88) .71
Other finding 
revascularization
0.31 (0.02-5.33) .42
Abbreviations: ACE, angiotensin-converting enzyme; ARB, angiotensin II
receptor blockers; CABG, coronary artery bypass graft; CHF, congestive heart
failure; COPD, chronic obstructive pulmonary disease; ExE, exercise
echocardiography; HR, hazard ratio; MET, metabolic equivalent for task;
MI, myocardial infarction.
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COMMENT
There are 5 major findings from this study of asymptom-
atic postrevascularization patients. First, only 262 (13%)
had evidence of ischemia. Second, abnormal test results
were associated with increased risks for subsequent over-
all and cardiac death in both early- and late-tested groups.
Third, themain predictor of outcomewas exercise capac-
ity, suggesting that risk evaluation could be obtained from
a standard exercise test rather than exercise echocardiog-
raphy. Fourth, ischemic results were often not acted on;
among patients with evidence of ischemia, 66% did not
undergo RVS, and of those who underwent RVS, 75% did
not have ischemia on their ExE. The decision to proceed
with RVS was based more on the change in the clinical
status of the patient with development of ischemic symp-
toms than on the sole result of the test. Finally, RVS was
not associated with more favorable outcomes.
RATIONALE FOR SCREENING
IN REVASCULARIZED PATIENTS
Coronary revascularization is highly effective for symp-
tom control, and changes the outcome of selected pa-
tient groups with extensive coronary disease.15 Unfortu-
nately, no revascularization procedures are curative, and
recurrent coronary problems are common, owing to stent
restenosis, graft closure or new native coronary le-
sions.1,2 Screening tests are often considered in the hope
of identifying and resolving these problems electively and
reducing the likelihood of acute presentations.
Based on previous prognostic studies, the appropriate
use criteria7 identify ExE as being of indeterminate value
late after PCI (2 years) and CABG (5 years), and in-
appropriate before this time frame. These judgmentswere
madeon thebasis of expert opinion and, in relation toprog-
nostic value, do not seem to be supported by our data. Pre-
vious studies have shown that stress echocardiography is
an accurate diagnostic tool for identifying significant coro-
nary stenoses after either PCI16,17 or CABG.18,19 Studies of
moderate size have shown stress echocardiography to have
prognostic value in asymptomatic patients postrevascu-
larization.4-6 Other functional tests (eg, exercise nuclear
perfusion imaging)20,21 have identified the detection of is-
chemia after 5 years as being associated with adverse out-
come. In contrastwith stress echocardiography, thenuclear
appropriateness criteria conclude that stress testing is ap-
propriate in asymptomatic patients 5 or more years after
CABG, and indeterminate at less than5 years afterCABG.22
However, the appropriateuse criteria indicate that the value
of risk assessment with single-photon emission com-
puted tomography in asymptomatic post-PCI patients is
uncertain, with no evidence of survival benefit.22,23 More-
over, the exercise testing and nuclear guidelines are dis-
cordant about the value of testing in selected asymptom-
atic, high-risk patients.24,25
APPROPRIATENESS OF TESTING
Unfortunately, it hasnotbeenwell establishedas towhether
the information provided by testing asymptomatic pa-
tients alters treatment, and, if so, whether such treatment
changes alter outcomes. This is a critical issue because the
detection of clinically silent coronary disease progression
may expose the patient to the risks and expense of further
revascularizationwithout a survival benefit. There are also
Table 5. Contribution of Clinical, Stress Testing, and Exercise Echocardiography (ExE) Results
in Prediction of Mortality From Nested Cox Regression Models
Type of Mortality Modela −2 Log Likelihood Likelihood Ratio 2 df P Value
All-cause mortality
Null model 0 2407.7
Clinical variables 1 2299.0 109.0 17 .001
Stress testing measures 2 2260.0 39.0 5 .001
ExE test results 3 2259.2 0.8 4 .94
Cardiac-related mortality
Null model 0 1265.6
Clinical variables 1 1187.9 77.7 17 .001
Stress testing measures 2 1147.7 40.2 5 .001
ExE test results 3 1145.9 1.8 4 .78
aModel 1: Clinical variables: age, sex, diabetes mellitus, hypertension, coronary artery bypass graft vs percutaneous coronary intervention, use of
cardioprotective agents (aspirin, angiotensin-converting enzyme inhibitors,  blockers, angiotensin II receptor blockers, statins), cardiac event history (history of
atrial fibrillation, congestive heart failure, myocardial infarction), current smoker, obesity, history of stroke, and chronic obstructive pulmonary disease. Model 2:
Cardiac-risk index, ejection fraction, exercise capacity (maximum metabolic equivalent for task), and Duke treadmill results. Model 3: Level of ischemia, level of
scar, nondiagnostic reading, and Wall Motion Stress Index at stress.
100
80
90
70
0 4 6 71 2 3 5 8 9 10
Time to Event, y
Su
rv
iv
al
 P
ro
ba
bi
lit
y,
 %
Ischemic with revascularization
Ischemic without revascularization
Nonischemic
Figure 3. Adjusted survival based on multivariate Cox regression models at
mean of covariates, according to the presence of ischemia and subsequent
revascularization.
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barriers to RVS, including comorbidities, lack of suitable
target vessels, potential revascularization of nonischemic
territory based on suitability of anatomy rather than physi-
ology, and difficulties in balancing the risk of another pro-
cedure with the risk of adverse outcome from ischemia.
Probably as a consequence, ischemic resultswere often not
acted on. In addition, it seems that RVS did not provide
prognostic benefit even among the asymptomatic patients
at highest risk.
The results of our study also somewhat contradict the
current guidelines about the selection of standard exer-
cise electrocardiography (ECG) and stress imaging tests
after revascularization. TheACC/AHAstress testing guide-
lines state that among patients who can attain an ad-
equate level of exercise, symptom-limited treadmill or bi-
cycle exercise is the preferred form of stress because it
provides themost information concerning patient symp-
toms, exercise capacity, cardiovascular function, and the
hemodynamic response during usual forms of activ-
ity.24 However, for diagnostic purposes in the postrevas-
cularization population, stress imaging tests are pro-
posed in preference to the standard exercise ECG, because
a number of ECG changes are nonspecific in this group.26
Our results suggest that from a prognostic standpoint, a
combination of clinical and exercise data is effective in
identifying patients at the highest risk, even though they
are unlikely to benefit from RVS. To our knowledge, no
previous study of exercise echocardiography in asymp-
tomatic patients postrevascularization addressed the in-
cremental value of imaging to clinical and stress testing
findings—all previous studies included eithermixed stress
modalities (exercise and pharmacologic) and/or had a
combination of asymptomatic and symptomatic pa-
tients. In the nuclear literature, a single-exercise, thallium-
perfusion testing study20 had a comparable population
in asymptomatic patients after CABG. In that work, Lauer
et al20 found that impaired exercise capacity was more
predictive of death (adjusted relative risk [RR], 4.16, 95%
CI, 2.38-7.29) andmajor events (adjusted RR, 3.61; 95%
CI, 2.22-5.87) than thallium-perfusion defects (ad-
justed RR, 2.78; 95% CI, 1.44-5.39 for death and ad-
justed RR, 2.63; 95% CI, 1.49-4.66 for major events) in
asymptomatic patients after CABG.
STUDY LIMITATIONS
This is an observational study, which shows associations
but cannot ascribe causality. However, while it is conceiv-
able that some patients may have a more favorable out-
come with RVS, this seems unlikely on the basis that risk
stratification failed to identify asymptomatic patients who
will benefit from RVS. Likewise, although these patients
were treated as a specialized referral center, the levels of
risk and risk factors seen in this study are compatible with
the usual postrevascularization patient. Finally, all of our
patients were testedwith exercise echocardiography, rais-
ing the question whether the results of this study are gen-
eralizable to all forms of stress testing.
In conclusion, the results of this study suggest that
asymptomatic patients who undergo treadmill ExE after
coronary revascularizationmaybe identifiedasbeingathigh
risk but donot seem tohavemore favorable outcomeswith
RVS.Given the very large population of post-PCI andpost-
CABG patients, careful consideration is warranted before
the screening of asymptomatic patients is considered ap-
propriate at any stage after revascularization.
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INVITED COMMENTARY
Routine Periodic Stress Testing in Asymptomatic
Patients Following Coronary Revascularization
Is It Worth the Effort?
T he confluence of increasing budgetary restric-tions and the proliferation of medical imagingmake the appropriateness of routine periodic
stress testing in asymptomatic patients following coro-
nary revascularization a hotly debated topic.1,2 Routine
periodic stress testing is still used by many physicians.
Putative reasons include surveillance for restenosis
after percutaneous coronary intervention (PCI), iden-
tification of graft patency after coronary artery bypass
graft (CABG) surgery, and determination of complete-
ness of revascularization. However, the usefulness of
routine periodic stress testing in asymptomatic
patients following coronary revascularization remains
unknown.
Stress testing can be performed with exercise alone
or in combination with echocardiographic or nuclear
imaging. Many studies have demonstrated the prognos-
tic ability of these tests, with ischemia demonstrated on
routine testing indicating worse prognosis.3 The addi-
tion of ventricular imaging to exercise testing alone in-
creases sensitivity, specificity, and prognostic ability. Un-
fortunately, there are little data to support the idea that
revascularizing asymptomatic patients on the basis of these
studies actually improves prognosis.
Guidelines and appropriateness statements abound that
touch on the issue of routine periodic stress testing after
coronary revascularization.Wehave statements about PCI,
CABG, stress testing, echocardiography, and nuclear
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